We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » India Again Requests Trial Protocols from Combo Drug Manufacturers
India Again Requests Trial Protocols from Combo Drug Manufacturers
The Drug Controller General of India asked manufacturers twice last year to submit Phase IV trial protocols— once in June and again in September — but most drugmakers have still not fulfilled the regulatory requirement.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor